| abstract |
Provided are specific quinazolines of formula (I) or (II) that are PDE10 inhibitors, pharmaceutical compositions containing them, and methods for their preparation. Also provided are methods of treating diseases that can be treated with the PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia or bipolar disorder, obsessive compulsive disorder, etc. by administering that particular quinazoline. [Selection figure] None |